2nd Hep-C Community Summit: We are more than just patients

17/09

The European AIDS Treatment Group participates in the 2nd Hep-C Community Summit that takes place on the 18th of September…

The European AIDS Treatment Group is looking for an Executive Director

11/09

Type of contract: Full-time, permanent contract Location: Brussels, Belgium Reporting to: Board of Directors Start date: As soon as possible…

Webinar: Patient Engagement on Medicines Research & Development

22/08

Join us for a webinar about patient engagement in the process of research and development of medicines on Thursday, September…

HIV treatment in Malta archaic, activist warns

20/09

Medication comes at a hefty price of €600 Treatment for human immunodeficiency virus (HIV) in Malta is “archaic” because doctors were prescribing…

US doctors’ organisation endorses event-based PrEP for the first time

20/09

For the first time, a US-based professional HIV body has published guidelines endorsing event-based or so-called ‘on-demand’ pre-exposure prophylaxis (PrEP)…

Cocrystal Pharma completes patient enrollment in Phase 2a study evaluating CC-31244 for ultra-short treatment of hepatitis C

20/09

ATLANTA, GA and BOTHELL, WA, Sept. 20, 2018 -- Cocrystal Pharma, Inc. (NASDAQ: COCP), (“Cocrystal” or the “Company”), a clinical stage biotechnology…

2nd Hep-C Community Summit: We are more than just patients

17/09

The European AIDS Treatment Group participates in the 2nd Hep-C Community Summit that takes place on the 18th of September…

The European AIDS Treatment Group is looking for an Executive Director

11/09

Type of contract: Full-time, permanent contract Location: Brussels, Belgium Reporting to: Board of Directors Start date: As soon as possible…

Webinar: Patient Engagement on Medicines Research & Development

22/08

Join us for a webinar about patient engagement in the process of research and development of medicines on Thursday, September…

HIV treatment in Malta archaic, activist warns

20/09

Medication comes at a hefty price of €600 Treatment for human immunodeficiency virus (HIV) in Malta is “archaic” because doctors were prescribing…

US doctors’ organisation endorses event-based PrEP for the first time

20/09

For the first time, a US-based professional HIV body has published guidelines endorsing event-based or so-called ‘on-demand’ pre-exposure prophylaxis (PrEP)…

Cocrystal Pharma completes patient enrollment in Phase 2a study evaluating CC-31244 for ultra-short treatment of hepatitis C

20/09

ATLANTA, GA and BOTHELL, WA, Sept. 20, 2018 -- Cocrystal Pharma, Inc. (NASDAQ: COCP), (“Cocrystal” or the “Company”), a clinical stage biotechnology…